Related references
Note: Only part of the references are listed.Management of multidrug-resistant tuberculosis in the Asia-Pacific region
Wing-Wai YEW
RESPIROLOGY (2008)
Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis:: epidemiology and control
Alberto Matteelli et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
New tuberculosis therapeutics: A growing pipeline
Melvin K. Spigelman
JOURNAL OF INFECTIOUS DISEASES (2007)
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps
Leonard Amaral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis
Marta Martins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Worldwide emergence of extensively drug-resistant tuberculosis
N. Sarita Shah et al.
EMERGING INFECTIOUS DISEASES (2007)
Life and death in the granuloma: immunopathology of tuberculosis
Bernadette M. Saunders et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections
Pierre Baudoux et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Maritza Barcia-Macay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Non-antibiotics: Alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries
Leonard Amaral et al.
CURRENT DRUG TARGETS (2006)
Mycobacterium tuberculosis and rifampin resistance, United kingdom
IC Sam et al.
EMERGING INFECTIOUS DISEASES (2006)
New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistance
Madhukar Pai et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2006)
Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis
Juan Carlos Palomino
CURRENT OPINION IN PULMONARY MEDICINE (2006)
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis
M Viveiros et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
LP Ormerod
BRITISH MEDICAL BULLETIN (2005)
Inhibition of the Carpobrotus edulis methanol extract on the growth of phagocytosed multidrug-resistant Mycobacterium tuberculosis and methicillin-resistant Staphylococcus aureus
M Martins et al.
FITOTERAPIA (2005)
Laboratory diagnostic aspects of drug resistant tuberculosis
LM Parsons et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Carpobrotus edulis methanol extract inhibits the MDR efflux pumps, enhances killing of phagocytosed S-aureus and promotes immune modulation
D Ordway et al.
PHYTOTHERAPY RESEARCH (2003)
Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis
D Ordway et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus
D Ordway et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Laboratory diagnosis of mycobacterial infections: New tools and lessons learned
YM Hale et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
